Literature DB >> 2375437

Evidence for less improvement in depression in patients taking benzodiazepines during unilateral ECT.

H M Pettinati1, S M Stephens, K M Willis, S E Robin.   

Abstract

Among 48 patients with diagnoses of depression according to DSM-III, there was a significant relation between therapeutic failure of unilateral ECT, as measured by scores on the Hamilton Rating Scale for Depression, and the concomitant use of a benzodiazepine. Of the 34 patients who showed a good therapeutic response to unilateral ECT, those taking benzodiazepines had smaller changes in their Hamilton depression ratings from before treatment to after treatment and were more symptomatic at the end of the course of ECT. Thus, when patients take benzodiazepines during a course of unilateral ECT, the maximum therapeutic response may be compromised.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2375437     DOI: 10.1176/ajp.147.8.1029

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  12 in total

Review 1.  Benzodiazepines. Depressants or antidepressants?

Authors:  J W Tiller; I Schweitzer
Journal:  Drugs       Date:  1992-08       Impact factor: 9.546

Review 2.  Continuation and maintenance electroconvulsive therapy for mood disorders: review of the literature.

Authors:  Georgios Petrides; Kristen G Tobias; Charles H Kellner; Matthew V Rudorfer
Journal:  Neuropsychobiology       Date:  2011-07-29       Impact factor: 2.328

3.  Structural Plasticity of the Hippocampus and Amygdala Induced by Electroconvulsive Therapy in Major Depression.

Authors:  Shantanu H Joshi; Randall T Espinoza; Tara Pirnia; Jie Shi; Yalin Wang; Brandon Ayers; Amber Leaver; Roger P Woods; Katherine L Narr
Journal:  Biol Psychiatry       Date:  2015-03-05       Impact factor: 13.382

4.  The practice of ect in India : issues relating yo the administration of ect.

Authors:  A K Agarwal; C Andrade; M V Reddy
Journal:  Indian J Psychiatry       Date:  1992-10       Impact factor: 1.759

Review 5.  A review of evidence for GABergic predominance/glutamatergic deficit as a common etiological factor in both schizophrenia and affective psychoses: more support for a continuum hypothesis of "functional" psychosis.

Authors:  R F Squires; E Saederup
Journal:  Neurochem Res       Date:  1991-10       Impact factor: 3.996

Review 6.  Interactions between psychotropics, anaesthetics and electroconvulsive therapy: implications for drug choice and patient management.

Authors:  Mohamed Naguib; Robert Koorn
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

7.  Position statement and guidelines on unmodified electroconvulsive therapy.

Authors:  Chittaranjan Andrade; N Shah; P Tharyan; M S Reddy; M Thirunavukarasu; R A Kallivayalil; R Nagpal; N K Bohra; A Sharma; E Mohandas
Journal:  Indian J Psychiatry       Date:  2012-04       Impact factor: 1.759

8.  Effects of zopicloone and Lorazepam on ect seizure duration : clinical implications of findings from an animal model.

Authors:  C Andrade; K P Reddy; B S Srihari; S Sudha; J S Chandra
Journal:  Indian J Psychiatry       Date:  2000-07       Impact factor: 1.759

9.  Clinical Effectiveness of Maintenance Electroconvulsive Therapy in Patients with Schizophrenia: A Retrospective Cohort Study.

Authors:  Moshe Isserles; Jesse Remington; Tyler S Kaster; Zafiris J Daskalakis; Daniel M Blumberger
Journal:  J ECT       Date:  2020-03       Impact factor: 3.692

10.  Differential response to right unilateral ECT in depressed patients: impact of comorbidity and severity of illness [ISRCTN39974945].

Authors:  Pertti Heikman; Heikki Katila; Seppo Sarna; Kristian Wahlbeck; Kimmo Kuoppasalmi
Journal:  BMC Psychiatry       Date:  2002-01-17       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.